Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FB2GY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,985
Award facts
- Contract value 100% obligated
- $10,984.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens with a ceiling value of $10,984.65 under a firm fixed-price arrangement. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, making this delivery order part of the Defense Health Agency's pharmaceutical supply chain for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA, consistently delivering specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains through competitively awarded, firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26FB2GY?
SPE2DR26FB2GY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FB2GY worth?
The government has obligated $10,985 on SPE2DR26FB2GY.
Is contract SPE2DR26FB2GY an order under another contract?
Yes. SPE2DR26FB2GY is a delivery order under SPE2DR25D2102, an indefinite delivery contract.
Was contract SPE2DR26FB2GY competed?
The extent of competition for SPE2DR26FB2GY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award